Journal article icon

Journal article

Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians

Abstract:

The Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging respiratory pathogen with a high mortality rate and no specific treatments available to date. The purpose of this study was to determine the feasibility of conducting a randomized controlled trial (RCT) of convalescent plasma therapy for MERS-CoV-infected patients by using MERS-CoV-specific convalescent plasma obtained from previously recovered patients.A survey was adapted from validated questionnaire originally aimed...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1186/s12871-016-0198-x

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
Publisher:
BioMed Central
Journal:
BMC anesthesiology More from this journal
Volume:
16
Issue:
36
Pages:
1-7
Publication date:
2016-07-12
Acceptance date:
2016-05-28
DOI:
ISSN:
1471-2253
Pmid:
27405596
Language:
English
Keywords:
Pubs id:
pubs:634923
UUID:
uuid:8cd3a77e-8d7e-4c59-9cec-735064ae96d4
Local pid:
pubs:634923
Source identifiers:
634923
Deposit date:
2017-08-18

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP